• Nuwellis announced publication of its multicenter ULTRA-Peds study results for the Aquadex SmartFlow system in Pediatric Nephrology.
• The study involved 91 pediatric patients across seven hospitals, supporting Aquadex's feasibility for kidney support in critically ill children, including infants.
• Most patients survived treatment, while most procedures were completed without interruption.
• The findings support efforts to expand FDA-cleared labeling from patients weighing 20 kg or more to those weighing at least 5 kg.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuwellis Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270800PRIMZONEFULLFEED9853778) on October 27, 2026, and is solely responsible for the information contained therein.